Oncopeptides, a global biotech company focused on the development of targeted therapies for difficult-to-treat hematological diseases, has announced that CFO Anders Martin-Löf will leave the company for personal reasons. Martin-Löf,…
Oncopeptides, a global biotech company focused on the development of targeted therapies for difficult-to-treat hematological diseases, has announced that CFO Anders Martin-Löf will leave the company for personal reasons. Martin-Löf,…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


